These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

849 related articles for article (PubMed ID: 26831903)

  • 1. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study.
    Sumita K; Harada H; Asakura H; Ogawa H; Onoe T; Murayama S; Nakamura S; Tanigawa N; Takahashi T; Nishimura T
    Radiat Oncol; 2016 Aug; 11():104. PubMed ID: 27485533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
    Chao HH; Berman AT; Simone CB; Ciunci C; Gabriel P; Lin H; Both S; Langer C; Lelionis K; Rengan R; Hahn SM; Prabhu K; Fagundes M; Hartsell W; Mick R; Plastaras JP
    J Thorac Oncol; 2017 Feb; 12(2):281-292. PubMed ID: 27826034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.
    McAvoy S; Ciura K; Wei C; Rineer J; Liao Z; Chang JY; Palmer MB; Cox JD; Komaki R; Gomez DR
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):819-27. PubMed ID: 25220718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
    Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
    Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spine radiosurgery: a dosimetric analysis in 124 patients who received 18 Gy.
    Schipani S; Wen W; Jin JY; Kim JK; Ryu S
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e571-6. PubMed ID: 22975607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame.
    Poltinnikov IM; Fallon K; Xiao Y; Reiff JE; Curran WJ; Werner-Wasik M
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):652-8. PubMed ID: 15936541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
    Singh AK; Lockett MA; Bradley JD
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):337-41. PubMed ID: 12527046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors.
    Nishimura S; Takeda A; Sanuki N; Ishikura S; Oku Y; Aoki Y; Kunieda E; Shigematsu N
    J Thorac Oncol; 2014 Sep; 9(9):1370-6. PubMed ID: 25122433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
    Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):626-9. PubMed ID: 15936536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence.
    Arthur DW; Winter KA; Kuerer HM; Haffty BG; Cuttino LW; Todor DA; Simone NL; Hayes SB; Woodward WA; McCormick B; Cohen RJ; Sahijdak WM; Canaday DJ; Brown DR; Currey AD; Fisher CM; Jagsi R; White J
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1028-1035. PubMed ID: 28721885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).
    Zehentmayr F; Söhn M; Exeli AK; Wurstbauer K; Tröller A; Deutschmann H; Fastner G; Fussl C; Steininger P; Kranzinger M; Belka C; Studnicka M; Sedlmayer F
    Radiat Oncol; 2015 May; 10():121. PubMed ID: 26018527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reirradiation for locally recurrent lung cancer previously treated with radiation therapy.
    Okamoto Y; Murakami M; Yoden E; Sasaki R; Okuno Y; Nakajima T; Kuroda Y
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):390-6. PubMed ID: 11872284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.
    Kim TH; Cho KH; Pyo HR; Lee JS; Han JY; Zo JI; Lee JM; Hong EK; Choi IJ; Park SY; Shin KH; Kim DY; Kim JY
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):995-1002. PubMed ID: 15990000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk.
    Zolciak-Siwinska A; Bijok M; Jonska-Gmyrek J; Kawczynska M; Kepka L; Bujko K; Michalski W
    Gynecol Oncol; 2014 Jan; 132(1):93-7. PubMed ID: 24161366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
    Ren C; Ji T; Liu T; Dang J; Li G
    Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiotherapy for central lung tumors.
    Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
    J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is re-irradiation effective in symptomatic local recurrence of non small cell lung cancer patients? A single institution experience and review of the literature.
    Cetingoz R; Arican-Alicikus Z; Nur-Demiral A; Durmak-Isman B; Bakis-Altas B; Kinay M
    J BUON; 2009; 14(1):33-40. PubMed ID: 19373944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer.
    Fernandes A; Berman AT; Mick R; Both S; Lelionis K; Lukens JN; Ben-Josef E; Metz JM; Plastaras JP
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):483-487. PubMed ID: 26847847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.